A Phase 1, Open-Label, Dose Escalation Study of ANA773 Tosylate, an Oral Prodrug of a Toll-Like Receptor-7 Agonist, in Patients with Advanced Cancer (Anadys Protocol #ANA773-501)
Phase of Trial: Phase I
Latest Information Update: 26 May 2011
At a glance
- Drugs RG 7795 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 26 May 2011 Results were reported in an Anadys media release and will be presented at the Annual Meeting of the American Society of Oncology (ASCO-2011).
- 26 May 2011 Status changed from not stated to completed.
- 24 Feb 2011 New trial record